Lv5
1440 积分 2024-01-08 加入
Safety, pharmacokinetics, and preliminary efficacy of VS-01, an intraperitoneal liposomal infusion, in patients with decompensated liver cirrhosis, ascites, and covert hepatic encephalopathy: a phase 1b, first-in-human, open-label, non-randomised, single ascending and multiple dose study
25天前
已完结
Corticosteroids in severe alcohol-associated hepatitis. Not so fast: A systematic review of randomized controlled trials
3个月前
已关闭
Changes in Liver Disease Etiology Support a Lower Alpha-Fetoprotein Threshold for Hepatocellular Carcinoma Screening
3个月前
已完结
Pre-emptive TIPS for gastric variceal bleeding in patients with cirrhosis (GAVAPROSEC): an open-label randomised clinical trial
6个月前
已完结
Pre-emptive TIPS for gastric variceal bleeding in patients with cirrhosis (GAVAPROSEC): an open-label randomised clinical trial
6个月前
已完结
Nonalcohol-related Cirrhosis Leads to Higher 6-week Mortality After Acute Variceal Bleeding Than Alcohol-related Cirrhosis
6个月前
已完结
Impact of metabolic dysfunction severity in steatotic liver disease and its interaction with liver fibrosis on all-cause mortality and multiple hepatic and extra-hepatic outcomes
6个月前
已关闭
Prognostic significance of mild ascites in patients with cirrhosis
8个月前
已完结
The Role of P-CABs in GERD
8个月前
已完结
Research Priorities and Future Landscape of Clinical Trials in Alcohol-Associated Liver Disease
8个月前
已完结
皖公网安备34019202002308
